WuXi PharmaTech Adds Key Executive to Management Team

Dr. Steve Yang has joined WuXi PharmaTech as Executive Vice President and Chief Operating Officer. Dr. Yang’s high-profile background combines deep knowledge of biopharma R&D in China and global pharma experience. For the past three years, he has been Vice President and Head of Asia and Emerging Markets iMed at AstraZeneca, based in Shanghai. Before that, he spent 10 years at Pfizer, also in Shanghai, as head of Asia R&D. Dr. Yang is a co-founder of BayHelix, an elite group of China-American biopharma executives and one of the returnees or "sea turtles" who is changing the face of the pharmaceutical industry in China. More details.... Stock Symbols: (NYSE: WX) (NYSE: AZN) (NYSE: PFE) Share this with colleagues: // //